Screener
Abbott ABT Medical Devices — Selling, general, and administrative
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Abbott in its filing.
Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.
The source filing: Abbott’s 10-Q, filed July 28, 2026.
- Filed
- Jul 28, 2026, 4:02 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050134
| (in millions) | Net Sales to External Customers / Three Months Ended June 30, 2026 | Net Sales to External Customers / Three Months Ended June 30, 2025 | Cost of Products Sold / Three Months Ended June 30, 2026 | Cost of Products Sold / Three Months Ended June 30, 2025 | Research and Development / Three Months Ended June 30, 2026 | Research and Development / Three Months Ended June 30, 2025 | Selling, General, and Administrative / Three Months Ended June 30, 2026 | Selling, General, and Administrative / Three Months Ended June 30, 2025 | Operating Earnings / Three Months Ended June 30, 2026 | Operating Earnings / Three Months Ended June 30, 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Established Pharmaceuticals | $1,499 | $1,383 | $(650) | $(631) | $(48) | $(43) | $(419) | $(363) | $382 | $346 |
| Nutritional Products | 2,144 | 2,212 | (1,148) | (1,155) | (54) | (54) | (574) | (585) | 368 | 418 |
| Diagnostic Products | 3,092 | 2,173 | (1,532) | (1,224) | (268) | (154) | (793) | (423) | 499 | 372 |
| Medical Devices | 5,853 | 5,369 | (1,925) | (1,758) | (470) | (430) | (1,489) | (1,385) | 1,969 | 1,796 |
| Total | $12,588 | $11,137 | $(5,255) | $(4,768) | $(840) | $(681) | $(3,275) | $(2,756) | $3,218 | $2,932 |
| Other | 5 | 5 | ||||||||
| Net sales | $12,593 | $11,142 | ||||||||
| Corporate functions and plan benefit costs | (45) | (65) |
Item 1. Financial Statements and Supplementary Data
FAQ
- What is Abbott's medical devices — selling, general, and administrative?
- Abbott (ABT) reported medical devices — selling, general, and administrative of $1.49B in Q2 2026.
- How has Abbott's medical devices — selling, general, and administrative changed year-over-year?
- Abbott's medical devices — selling, general, and administrative increased by 7.5% year-over-year, from $1.39B to $1.49B.
- What is the long-term trend for Abbott's medical devices — selling, general, and administrative?
- Over 3 years (2022 to 2025), Abbott's medical devices — selling, general, and administrative has grown at a 10.2% compound annual growth rate (CAGR), from $4.07B to $5.45B.
- What does medical devices — selling, general, and administrative mean?
- Represents the overhead costs associated with operating the medical devices segment, including sales force compensation, marketing, legal, and administrative support. This metric measures the efficiency of the segment's support structure and commercial organization. It is a key lever for managing operating margins.
Ask your AI about Abbott's medical devices — selling, general, and administrative.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude